M&A Deal Summary |
|
|---|---|
| Date | 2016-01-08 |
| Target | Bako |
| Sector | Healthcare Services |
| Buyer(s) | Consonance Capital Partners |
| Sellers(s) | Ampersand Capital Partners |
| Deal Type | Recapitalization |
| Advisor(s) | Leerink Partners (Financial) Goodwin Procter (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 2005 |
| PE ASSETS | 1.3B USD |
| Size | Large |
| Type | Sector Focused |
Consonance Capital Partners is a healthcare-focused private investment firm focused on both public and private equity investing. The Firm's private equity group targets growth equity, leveraged buyouts, and recapitalization transactions in lower middle-market companies with $25 to $500 million of revenue. Specific areas of interest include healthcare providers, mayors, distribution, medical devices, specialty pharmaceuticals, outsourced services, and healthcare IT. Consonance Capital Partners was formed in 2005 and is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 9 |
| Sector (Healthcare Services) | 3 of 5 |
| Type (Recapitalization) | 1 of 4 |
| State (Georgia) | 1 of 1 |
| Country (United States) | 3 of 9 |
| Year (2016) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-05-07 |
Kepro
Nashville, Tennessee, United States Kepro is a quality improvement and care management organization that offers innovative and outcomes-focused solutions to reduce the utilization of healthcare resources and optimize the quality of care for government and private sector clients. Kepro's comprehensive, member-centric care management solutions go far beyond traditional utilization and case management by coordinating the care provided to members with acute, chronic and complex conditions across the continuum, and identifying members who are at the highest risk for future services but have not yet had an acute event. Kepro was founded in 1985 and is based in Nashville, Tennessee. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-02-28 |
Corindus Vascular Robotics
Waltham, Massachusetts, United States Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The Company’s CorPath® platform is the first FDA-cleared medical device to bring robotic precision to percutaneous coronary and vascular procedures. CorPath GRX is the second-generation robotic-assisted technology offering enhancements to the platform by adding important key upgrades that increase precision, improve workflow, and extend the capabilities and range of procedures that can be performed robotically. We are focused on developing innovative robotic solutions to revolutionize the treatment of emergent conditions by providing specialized and timely medical care to patients around the world. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 23 of 55 |
| Sector (Healthcare Services) | 2 of 3 |
| Type (Recapitalization) | 2 of 2 |
| State (Georgia) | 1 of 1 |
| Country (United States) | 23 of 51 |
| Year (2016) | 1 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-11-19 |
Florida Biologix
Alachua, Florida, United States Florida Biologix is a provider of biopharmaceutical development, manufacturing, and testing services to the biotechnology industry and to biomedical research institutions. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-01-11 |
GENEWIZ
South Plainfield, New Jersey, United States GENEWIZ, Inc. is a provider of R&D genomics services that enable research scientists within pharmaceutical, biotechnology, agriculture, environmental and clean energy, academic, and government institutions to advance their discoveries. GENEWIZ, Inc. was founded in 1999 and is based in South Plainfield, New Jersey. |
Buy | - |
